BAMF
HRMY icon

BI Asset Management Fondsmaeglerselskab’s Harmony Biosciences HRMY Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,798
Closed -$185K – 481
2022
Q1 		$185K Buy
+3,798
New +$155K 0.01% 404

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's HRMY Position: Q2 2022 in Review

BI Asset Management Fondsmaeglerselskab sold out of Harmony Biosciences (HRMY) in Q2 2022, closing a stake of 3,798 shares — an estimated $185K sold.

BI Asset Management Fondsmaeglerselskab first reported a position in HRMY in Q1 2022 and held it in 1 quarter. The position peaked at $185K in Q1 2022. 183 funds tracked by Wall St. Rank hold HRMY as of Q2 2022.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Harmony Biosciences position as of Q2 2022 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 3,798 Harmony Biosciences shares in Q2 2022, an estimated $185K.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Harmony Biosciences in Q1 2022 and held it in 1 quarter.
  • BI Asset Management Fondsmaeglerselskab's Harmony Biosciences position peaked at $185K in Q1 2022.
  • 183 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2022.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2022, filed 12 Aug 2022.